Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director
CC transcript
Director departure

ANESIVA, INC. (ANSV) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/09/2010 25-NSE Form 25-NSE -
02/04/2010 SC 13G/A Alta Partners VIII, L.P. reports a 16.6% stake in ANESIVA, INC.
01/08/2010 4 JANNEY DANIEL (10% Owner) has filed a Form 4 on ANESIVA, INC.
Txns: Sold 372,999 shares @ $0.0918, valued at $34.2k
Sold 30,612 shares @ $0.0918, valued at $2.8k
Sold 1,039 shares @ $0.0918, valued at $95.4
01/08/2010 4 Alta Partners VIII, L.P. (10% Owner) has filed a Form 4 on ANESIVA, INC.
12/17/2009 8-K Quarterly results
12/09/2009 8-K Form 8-K - Current report
12/08/2009 8-K Form 8-K - Current report
12/04/2009 8-K Form 8-K - Current report
11/16/2009 10-Q Quarterly Report for the period ended September 30, 2009
11/10/2009 8-K Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
10/30/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "ANESIVA ANNOUNCES DATE FOR 2009 ANNUAL MEETING OF STOCKHOLDERS TO VOTE ON PROPOSED MERGER"
10/30/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/30/2009 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
10/27/2009 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
10/23/2009 8-K Termination of a Material Definitive Agreement
10/21/2009 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
10/06/2009 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
09/25/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "ANESIVA RECEIVES NASDAQ LISTING COMPLIANCE NOTICE"
09/25/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/18/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/17/2009 8-K/A Other Events, Financial Statements and Exhibits
Docs: "Revised Form of presentation of Anesiva, Inc"
09/17/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/17/2009 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
09/11/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/11/2009 8-K Other Events
08/25/2009 8-K Form 8-K - Current report
08/25/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/21/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/17/2009 8-K Cost Associated with Exit or Disposal Activities
08/07/2009 10-Q Quarterly Report for the period ended June 30, 2009
08/05/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/05/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/05/2009 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger among Anesiva, Inc., Arca Acquisition Corporation, Arcion Therapeutics, Inc. and, with respect to Articles V and IX only, each of the Arcion stockholders listed on Schedule I",
"Registration Rights Agreement, by and among Anesiva, Inc. and the entities identified on Schedule A thereto",
"Amendment No. 2 to Securities Purchase Agreement, by and between Anesiva, Inc. and Sofinnova Venture Partners VII, L.P., Alta California Partners III, L.P., Alta Embarcadero Partners III, LLC, Alta Partners VIII, LP, CMEA Ventures VII, L.P., CMEA Ventures VII (Parallel), L.P., InterWest Partners VIII, LP, InterWest Investors VIII, LP, and InterWest Investors Q VIII, LP",
"Reinvestment Agreement, by and among Anesiva, Inc., Arcion Therapeutics, Inc., and Sofinnova Venture Partners VII, L.P., Alta California Partners III, L.P., Alta Embarcadero Partners III, LLC, Alta Partners VIII, LP, CMEA Ventures VII, L.P., CMEA Ventures VII (Parallel), L.P., InterWest Partners VIII, LP, InterWest Investors VIII, LP, and InterWest Investors Q VIII, LP",
"Amended and Restated Executive Change in Control and Severance Benefit Plan, as amended",
"Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement -Creates New Company Focused on Targeted Pain Therapeutics that Address Large Markets With Unmet Needs- -Conference Call Scheduled for Wednesday, August 5, 2009 at 8:30 AM EDT-"
07/23/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy